“Epidermal Growth Factor Polymorphism Most Prevalent in Stage II Cervical Carcinoma”. Universa Medicina 33, no. 3 (December 2, 2014): 192–198. Accessed April 3, 2025. https://univmed.org/ejurnal/index.php/medicina/article/view/31.